Vnitr Lek 2008, 54(5):494-498

Examination of the kidneys in a diabetic patient

V. Tesař
Klinika nefrologie 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Vladimír Tesař, DrSc.

Diabetic nephropathy is the most frequent cause of terminal renal failure in the Czech Republic today. Diabetic patients should be screened for diabetic kidney disease on an annual basis, starting 5 years after diabetes was diagnosed in type 1 diabetes patients and immediately after diagnosis in type 2 diabetes patients. The screening includes determining the albumin/creatinine ratio from a urine sample, and of serum creatinine, and the calculation of glomerular filtration rate. In patients in whom microalbuminuria and/or proteinuria were found, measures should be taken to reduce cardiovascular risk and to slow down the progression of renal disease. In diabetic patients with abnormal urine test results detailed nephrology examination is necessary to exclude other renal diseases than diabetic nephropathy, especially chronic glomerulonephritis and ischaemic nephropathy.

Keywords: diabetes mellitus; diabetic nephropathy; albuminuria; proteinuria; albumin, creatinine ratio

Received: April 1, 2008; Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tesař V. Examination of the kidneys in a diabetic patient. Vnitr Lek. 2008;54(5):494-498.
Download citation

References

  1. American Diabetes Association: Clinical Practice Recommendations 2005. Diabetes Care 2005; 28(Suppl 1): S1-S79. Go to original source... Go to PubMed...
  2. Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis 2006; 47: 927-946. Go to original source... Go to PubMed...
  3. Costacou T, Ellis D, Fried L et al. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis 2007; 50: 721-732. Go to original source... Go to PubMed...
  4. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266.
  5. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003; 41(Suppl 3): S1-S91.
  6. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(Suppl 3): S1-S153.
  7. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49(Suppl 2): S1-S154. Go to original source... Go to PubMed...
  8. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-470. Go to original source... Go to PubMed...
  9. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004; 27: 195-200. Go to original source... Go to PubMed...
  10. Pham TT, Sim JJ, Kujubu DA et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 2007; 27: 322-328. Go to original source... Go to PubMed...
  11. Rigalleau V, Lasseur C, Raffaitin C et al. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group. Diabetes Care 2007; 30: 2034-2039. Go to original source... Go to PubMed...
  12. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria. Kidney Int 2006; 70: 1214-1222. Go to original source... Go to PubMed...
  13. Vora JP et al. Clinical manifestations and natural history of diabetic nephropathy. In: Johnson RJ, Feehally J. Comprehensive clinical nephrology. London: Mosby 2000: 34.1.-34.12.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.